Abstract Introduction Subcortical hyperintensities (SHs) are radiological entities commonly observed on magnetic resonance imaging (MRI) of patients with Alzheimer’s disease (AD) and normal elderly controls. Although the presence of SH is believed to indicate some form of subcortical vasculopathy, pathological heterogeneity, methodological differences, and the contribution of brain atrophy associated with AD pathology have yielded inconsistent results in the literature. Methods Using the Lesion Explorer (LE) MRI processing pipeline for SH quantification and brain atrophy, this study examined SH volumes of interest and cognitive funct...
Background/Aims: A quantitative method was applied to measure the volume of white matter hyperintens...
Background/Aims: A quantitative method was applied to measure the volume of white matter hyperintens...
Background: White matter hyperintensities (WMHs) are related to cognitive dysfunction in the general...
Abstract Introduction Subcortical hyperintensities (S...
Subcortical hyperintensities (SH) are believed to be observable signs of cerebrovascular disease, in...
The presence of white matter hyperintensities (WMH) and silent infarcts on magnetic resonance imagin...
Introduction: Hippocampal atrophy is an established Alzheimer’s Disease (AD) biomarker. Volume loss ...
The goal of this study was to examine the relationship between subcortical vascular disease and brai...
Background: White matter hyperintensities (WMH) on MRI scans indicate lesions of the subcortical fib...
White matter hyperintensities (WMH), a marker of small vessel cerebrovascular disease, increase risk...
Introduction: White matter hyperintensities (WMH) are often described in Alzheimer's disease (AD), b...
Objective To investigate whether subcortical grey matter atrophy predicts progression from mild cogn...
Background:Research in older adults with subjective cognitive decline (SCD) has mainly focused on Al...
Neuroimaging measures of Alzheimer’s disease (AD) include grey matter volume (GMV) alterations in th...
Background/Aims: A quantitative method was applied to measure the volume of white matter hyperintens...
Background/Aims: A quantitative method was applied to measure the volume of white matter hyperintens...
Background: White matter hyperintensities (WMHs) are related to cognitive dysfunction in the general...
Abstract Introduction Subcortical hyperintensities (S...
Subcortical hyperintensities (SH) are believed to be observable signs of cerebrovascular disease, in...
The presence of white matter hyperintensities (WMH) and silent infarcts on magnetic resonance imagin...
Introduction: Hippocampal atrophy is an established Alzheimer’s Disease (AD) biomarker. Volume loss ...
The goal of this study was to examine the relationship between subcortical vascular disease and brai...
Background: White matter hyperintensities (WMH) on MRI scans indicate lesions of the subcortical fib...
White matter hyperintensities (WMH), a marker of small vessel cerebrovascular disease, increase risk...
Introduction: White matter hyperintensities (WMH) are often described in Alzheimer's disease (AD), b...
Objective To investigate whether subcortical grey matter atrophy predicts progression from mild cogn...
Background:Research in older adults with subjective cognitive decline (SCD) has mainly focused on Al...
Neuroimaging measures of Alzheimer’s disease (AD) include grey matter volume (GMV) alterations in th...
Background/Aims: A quantitative method was applied to measure the volume of white matter hyperintens...
Background/Aims: A quantitative method was applied to measure the volume of white matter hyperintens...
Background: White matter hyperintensities (WMHs) are related to cognitive dysfunction in the general...